Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  36 results for ""Dipeptidyl-Peptidase IV Inhibitors""

Your Filters

Subject : biomarkers
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Sodium-glucose cotransporter 2 inhibitors compared with other glucose-lowering drugs in Japan: Subanalyses of the CVD-REAL 2 Study.

  • Authors : Kohsaka S; Department of Cardiology, Keio University School of Medicine, Tokyo, Japan.; Takeda M

Subjects: Biomarkers/Biomarkers/Biomarkers/*analysis ; Cardiovascular Diseases/Cardiovascular Diseases/Cardiovascular Diseases/*prevention & control ; Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*drug therapy

  • Source: Journal of diabetes investigation [J Diabetes Investig] 2021 Jan; Vol. 12 (1), pp. 67-73. Date of Electronic Publication: 2020 Jul 26.Publisher: Asian Association for the Study of Diabetes and Blackwell Pub. Asia Country of Publication: Japan NLM ID: 101520702 Publication Model:

Record details

Read More Add to Saved list
×
Academic Journal

Comparisons between dipeptidyl peptidase-4 inhibitors and other classes of hypoglycemic drugs using two distinct biomarkers of pancreatic beta-cell function: A meta-analysis.

  • Authors : Takahashi M; Department of Pharmacotherapy, Meiji Pharmaceutical University, Kiyose City, Tokyo, Japan.; Shibasaki M

Subjects: Biomarkers/Biomarkers/Biomarkers/*metabolism ; Dipeptidyl-Peptidase IV Inhibitors/Dipeptidyl-Peptidase IV Inhibitors/Dipeptidyl-Peptidase IV Inhibitors/*pharmacology ; Hypoglycemic Agents/Hypoglycemic Agents/Hypoglycemic Agents/*pharmacology

  • Source: PloS one [PLoS One] 2020 Jul 24; Vol. 15 (7), pp. e0236603. Date of Electronic Publication: 2020 Jul 24 (Print Publication: 2020).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Switching From Daily DPP-4 Inhibitor to Once-Weekly GLP-1 Receptor Activator Dulaglutide Significantly Ameliorates Glycemic Control in Subjects With Poorly Controlled Type 2 Diabetes Mellitus: A Retrospective Observational Study.

  • Authors : Sanada J; Department of Diabetes, Endocrinology and Metabolism, Kawasaki Medical School, Kurashiki, Japan.; Kimura T

Subjects: Biomarkers/Biomarkers/Biomarkers/*blood ; Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*drug therapy ; Dipeptidyl-Peptidase IV Inhibitors/Dipeptidyl-Peptidase IV Inhibitors/Dipeptidyl-Peptidase IV Inhibitors/*therapeutic use

  • Source: Frontiers in endocrinology [Front Endocrinol (Lausanne)] 2021 Aug 06; Vol. 12, pp. 714447. Date of Electronic Publication: 2021 Aug 06 (Print Publication: 2021).Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101555782 Publication Model: eCollection Cited Medium: Print

Record details

Read More Add to Saved list
×
Academic Journal

Analysis of the Adherence and Safety of Second Oral Glucose-Lowering Therapy in Routine Practice From the Mediterranean Area: A Retrospective Cohort Study.

  • Authors : Vlacho B; Grup de Recerca Epidemiològica en Diabetis des de l'Atenció Primària (DAP-CAT) Group, Unitat de Suport a la Recerca Barcelona, Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain.; Clinical Trials Unit, Germans Trias i Pujol Health Science Research Institute (IGTP), Barcelona, Spain.

Subjects: Biomarkers/Biomarkers/Biomarkers/*blood ; Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*drug therapy ; Dipeptidyl-Peptidase IV Inhibitors/Dipeptidyl-Peptidase IV Inhibitors/Dipeptidyl-Peptidase IV Inhibitors/*therapeutic use

  • Source: Frontiers in endocrinology [Front Endocrinol (Lausanne)] 2021 Jul 14; Vol. 12, pp. 708372. Date of Electronic Publication: 2021 Jul 14 (Print Publication: 2021).Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101555782 Publication Model: eCollection Cited Medium: Print

Record details

Read More Add to Saved list
×
Academic Journal

Risk of cardiovascular events and death associated with initiation of SGLT2 inhibitors compared with DPP-4 inhibitors: an analysis from the CVD-REAL 2 multinational cohort study.

Subjects: Biomarkers/Biomarkers/Biomarkers/*analysis ; Cardiovascular Diseases/Cardiovascular Diseases/Cardiovascular Diseases/*mortality ; Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*mortality

  • Source: The lancet. Diabetes & endocrinology [Lancet Diabetes Endocrinol] 2020 Jul; Vol. 8 (7), pp. 606-615.Publisher: The Lancet, Diabetes & Endocrinology Country of Publication: England NLM ID: 101618821 Publication Model: Print Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

Receptor-Mediated Bioassay Reflects Dynamic Change of Glucose-Dependent Insulinotropic Polypeptide by Dipeptidyl Peptidase 4 Inhibitor Treatment in Subjects With Type 2 Diabetes.

  • Authors : Yanagimachi T; Division of Metabolism and Biosystemic Science, Department of Internal Medicine, Asahikawa Medical University, Asahikawa, Japan.; Fujita Y

Subjects: Biomarkers/Biomarkers/Biomarkers/*blood ; Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*blood ; Dipeptidyl-Peptidase IV Inhibitors/Dipeptidyl-Peptidase IV Inhibitors/Dipeptidyl-Peptidase IV Inhibitors/*administration & dosage

  • Source: Frontiers in endocrinology [Front Endocrinol (Lausanne)] 2020 Apr 24; Vol. 11, pp. 214. Date of Electronic Publication: 2020 Apr 24 (Print Publication: 2020).Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101555782 Publication Model: eCollection Cited Medium: Print

Record details

Read More Add to Saved list
×
Academic Journal

Comparing treatment intensification and clinical outcomes of metformin and dipeptidyl peptidase-4 inhibitors in treatment-naïve patients with type 2 diabetes in Japan.

  • Authors : Horii T; Pharmacy Practice and Science I, Research and Education Center for Clinical Pharmacy, Kitasato University School of Pharmacy, Sagamihara, Kanagawa, Japan.; Iwasawa M

Subjects: Biomarkers/Biomarkers/Biomarkers/*analysis ; Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*drug therapy ; Dipeptidyl-Peptidase IV Inhibitors/Dipeptidyl-Peptidase IV Inhibitors/Dipeptidyl-Peptidase IV Inhibitors/*therapeutic use

  • Source: Journal of diabetes investigation [J Diabetes Investig] 2020 Jan; Vol. 11 (1), pp. 96-100. Date of Electronic Publication: 2019 Jun 21.Publisher: Asian Association for the Study of Diabetes and Blackwell Pub. Asia Country of Publication: Japan NLM ID: 101520702 Publication Model:

Record details

Read More Add to Saved list
×
Academic Journal

Metabolic effectiveness of gliflozins and gliptins in the routine clinical practice of patients with type 2 diabetes: preliminary results from GIOIA, a prospective multicentre study.

  • Authors : Esposito K; Diabetes Division, Department of Advanced Medical and Surgical Sciences, University of Campania 'Luigi Vanvitelli', Naples, Italy.; Longo M

Subjects: Biomarkers/Biomarkers/Biomarkers/*analysis ; Blood Glucose/Blood Glucose/Blood Glucose/*analysis ; Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*drug therapy

  • Source: Diabetes research and clinical practice [Diabetes Res Clin Pract] 2019 Sep; Vol. 155, pp. 107787. Date of Electronic Publication: 2019 Jul 19.Publisher: Elsevier Scientific Publishers Country of Publication: Ireland NLM ID: 8508335 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

Effect of switching to teneligliptin from other dipeptidyl peptidase-4 inhibitors on glucose control and renoprotection in type 2 diabetes patients with diabetic kidney disease.

  • Authors : Kitada M; Department of Diabetology and Endocrinology, Kanazawa Medical University, Uchinada, Ishikawa, Japan.; Division of Anticipatory Molecular Food Science and Technology, Medical Research Institute, Kanazawa Medical University, Uchinada, Ishikawa, Japan.

Subjects: Biomarkers/Biomarkers/Biomarkers/*analysis ; Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*drug therapy ; Diabetic Nephropathies/Diabetic Nephropathies/Diabetic Nephropathies/*prevention & control

  • Source: Journal of diabetes investigation [J Diabetes Investig] 2019 May; Vol. 10 (3), pp. 706-713. Date of Electronic Publication: 2018 Oct 01.Publisher: Asian Association for the Study of Diabetes and Blackwell Pub. Asia Country of Publication: Japan NLM ID: 101520702 Publication Model:

Record details

Read More Add to Saved list
×
Academic Journal

Efficacy and safety of sitagliptin in elderly patients with type 2 diabetes mellitus: A focus on hypoglycemia.

Subjects: Biomarkers/Biomarkers/Biomarkers/*analysis ; Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*drug therapy ; Dipeptidyl-Peptidase IV Inhibitors/Dipeptidyl-Peptidase IV Inhibitors/Dipeptidyl-Peptidase IV Inhibitors/*therapeutic use

  • Source: Journal of diabetes investigation [J Diabetes Investig] 2019 Mar; Vol. 10 (2), pp. 383-391. Date of Electronic Publication: 2018 Sep 25.Publisher: Asian Association for the Study of Diabetes and Blackwell Pub. Asia Country of Publication: Japan NLM ID: 101520702 Publication Model:

Record details

Read More Add to Saved list
×
  • 1-10 of  36 results for ""Dipeptidyl-Peptidase IV Inhibitors""